Anifrolumab

Records for this ingredient, by country (identity only).

ATC L04AG11 · 10 markets · 18 records

Anifrolumab 10 markets · 18 records Forms
Filters

AU 4 records · 3 shown of 3 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 300 mg/2 mLinjectionSAPHNELO also in US·JP·FR
  • 300 mg per mL / per unit basis not statedinjectionSAPHNELO anifrolumab 300 mg concentrated injection vial unknown
  • 120 mg per mL / per unit basis not statedinjectionSAPHNELO anifrolumab 120 mg (150 mg/mL) solution for injection in pre-filled pen unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

US 2 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

CA 2 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 150 mg per mL / per unit basis not statedliquidSAPHNELO
  • 120 mg per mL / per unit basis not statedliquidSAPHNELO

ES 2 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

MX 2 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名SAPHNELO ×2SAPHNELO SC ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

JP 2 records · 2 shown of 2 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 300 mg/2 mLinjectionサフネロー点滴静注300mg also in AU·US·FR
  • 120 mg/0.8 mLinjectionサフネロー皮下注120mgオートインジェクター also in US

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室(香港)註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名SAPHNELO CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/2ML ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 300 mg/2 mLinjectionSAPHNELO 300 mg, solution à diluer pour perfusion also in AU·US·JP

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.